Clinical Trial Details
| Trial ID: | L3833 |
| Source ID: | NCT03601910 |
| Associated Drug: | D308 10mg Tab. |
| Title: | Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg |
| Acronym: | |
| Status: | UNKNOWN |
| Study Results: | NO |
| Results: | |
| Conditions: | Type II Diabetes Mellitus |
| Interventions: | DRUG: D308 10mg Tab.|DRUG: CKD-380 10mg Tab. |
| Outcome Measures: | Primary: AUCt of CKD-380 and D308, Area under the CKD-380/D308 concentration in blood-time curve from zero to the final, Pre-dose(0 hour), post-dose 0.17, 0.33, 0.5, 0.75, 1, 1.5, 2, 3, 4, 6, 8, 12, 24, 36, 48 hours|Cmax of CKD-380 and D308, The maximum CKD-380/D308 concentration in blood sampling time t, Pre-dose(0 hour), post-dose 0.17, 0.33, 0.5, 0.75, 1, 1.5, 2, 3, 4, 6, 8, 12, 24, 36, 48 hours | |
| Sponsor/Collaborators: | Sponsor: Chong Kun Dang Pharmaceutical |
| Gender: | MALE |
| Age: | ADULT |
| Phases: | PHASE1 |
| Enrollment: | 34 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2018-07-16 |
| Completion Date: | 2018-11-09 |
| Results First Posted: | |
| Last Update Posted: | 2018-07-26 |
| Locations: | The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul, Korea, Republic of |
| URL: | https://clinicaltrials.gov/show/NCT03601910 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|